Unknown

Dataset Information

0

IL-4R? signaling in CD4+CD25+FoxP3+ T regulatory cells restrains airway inflammation via limiting local tissue IL-33.


ABSTRACT: Impaired tolerance to innocuous particles during allergic asthma has been linked to increased plasticity of FoxP3+ regulatory T cells (Tregs) reprogramming into pathogenic effector cells, thus exacerbating airway disease. However, failure of tolerance mechanisms is driven by Th2 inflammatory signals. Therefore, the in vivo role of canonical IL-4 receptor ? (IL-4R?) signaling, an essential driver of Th2-type airway responses to allergens, on the regulatory function of FoxP3+ Tregs in allergic asthma was explored. Here, we used transgenic Foxp3cre IL-4R?-/lox and littermate control mice to investigate the role of IL-4 and IL-13 signaling via Tregs in house dust mite-induced (HDM-induced) allergic airway disease. We sensitized mice intratracheally on day 0, challenged them on days 6-10, and analyzed airway hyperresponsiveness (AHR), airway inflammation, mucus production, and cellular profile on day 14. In the absence of IL-4R? responsiveness on FoxP3+ Tregs, exacerbated AHR and airway inflammation were shown in HDM-sensitized mice. Interestingly, reduced induction of FoxP3+ Tregs accompanied increased IL-33 alarmin production and type 2 innate lymphoid cell activation in the lung, exacerbating airway hyperreactivity and lung eosinophilia. Taken together, our findings indicate that IL-4R?-unresponsive FoxP3+ Tregs result in exaggerated innate Th2-type, IL-33-dependent airway inflammation and a break in tolerance during allergic asthma.

SUBMITTER: Khumalo J 

PROVIDER: S-EPMC7605533 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5436540 | BioStudies
2011-01-01 | S-EPMC3139332 | BioStudies
2020-01-01 | S-EPMC7641252 | BioStudies
2020-01-01 | S-EPMC7581806 | BioStudies
2019-01-01 | S-EPMC6688084 | BioStudies
2018-01-01 | S-EPMC6143420 | BioStudies
2018-01-01 | S-EPMC5924426 | BioStudies
2016-01-01 | S-EPMC5117775 | BioStudies
1000-01-01 | S-EPMC3051906 | BioStudies
2020-01-01 | S-EPMC7287160 | BioStudies